103 related articles for article (PubMed ID: 28278322)
1. Promoter Hypermethylation of GATA3, IL-4, and TGF-β Confers Susceptibility to Vogt-Koyanagi-Harada Disease in Han Chinese.
Zhu Y; Yu H; Qiu Y; Ye Z; Su W; Deng J; Cao Q; Yuan G; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1529-1536. PubMed ID: 28278322
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
3. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
4. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
[TBL] [Abstract][Full Text] [Related]
6. Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome.
Liao D; Hou S; Zhang J; Fang J; Liu Y; Bai L; Cao Q; Kijlstra A; Yang P
Sci Rep; 2015 Apr; 5():9511. PubMed ID: 25873156
[TBL] [Abstract][Full Text] [Related]
7. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet's disease.
Zhu Y; Qiu Y; Yu H; Yi S; Su W; Kijlstra A; Yang P
Oncotarget; 2017 Sep; 8(38):64263-64272. PubMed ID: 28969068
[TBL] [Abstract][Full Text] [Related]
9. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
Chang R; Yi S; Tan X; Huang Y; Wang Q; Su G; Zhou C; Cao Q; Yuan G; Kijlstra A; Yang P
Br J Ophthalmol; 2018 Feb; 102(2):282-290. PubMed ID: 28972028
[TBL] [Abstract][Full Text] [Related]
11. Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behcet's disease in the Chinese Han population.
Chen Y; Yang P; Li F; Hou S; Jiang Z; Shu Q; Kijlstra A
Curr Eye Res; 2012 Apr; 37(4):312-7. PubMed ID: 22440163
[TBL] [Abstract][Full Text] [Related]
12. Association of ATG5 Gene Polymorphisms With Behçet's Disease and ATG10 Gene Polymorphisms With VKH Syndrome in a Chinese Han Population.
Zheng M; Yu H; Zhang L; Li H; Liu Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8280-7. PubMed ID: 26747760
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
Wang C; Wang L; Hu J; Li H; Kijlstra A; Yang P
Curr Eye Res; 2018 Nov; 43(11):1369-1373. PubMed ID: 29877734
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of Interferon Regulatory Factor 8 (IRF8) Confers Risk to Vogt-Koyanagi-Harada Disease.
Qiu Y; Yu H; Zhu Y; Ye Z; Deng J; Su W; Cao Q; Yuan G; Kijlstra A; Yang P
Sci Rep; 2017 Apr; 7(1):1007. PubMed ID: 28432342
[TBL] [Abstract][Full Text] [Related]
16. TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
Zhang W; Chen Z; Yi K; Su G; Liu Y; Deng Y; Zhang Y; Cao Q; Pu Y; Luo X; Lai Y; Yang P
Clin Immunol; 2023 May; 250():109323. PubMed ID: 37019422
[TBL] [Abstract][Full Text] [Related]
17. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
18. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
Ye Z; Wang C; Tang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P
J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the association of Vogt-Koyanagi-Harada syndrome with IL23R-C1orf141 in Han Chinese Singaporean and ADO-ZNF365-EGR2 in Thai.
Cao S; Chee SP; Yu HG; Sukavatcharin S; Wu L; Kijlstra A; Hou S; Yang P
Br J Ophthalmol; 2016 Mar; 100(3):436-42. PubMed ID: 26628628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
